A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil

Trial Profile

A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Aug 2014

At a glance

  • Drugs Elenbecestat (Primary) ; Digoxin; Donepezil; Itraconazole; Rifampicin
  • Indications Alzheimer's disease
  • Focus Pharmacokinetics
  • Sponsors Eisai Inc
  • Most Recent Events

    • 18 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials .gov record
    • 31 Mar 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials .gov record.
    • 17 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top